This study is being done to to develop, assess, and refine a brief electronic survey tool, the Care Tracker, that can be completed weekly at home on a computer or smartphone, by patients with newly diagnosed breast and colorectal cancer. The survey will allow patients to self-report progress from their cancer diagnosis to starting treatment. The long-term goal of this research is to alert care teams when patients may be at risk of treatment days and to help patients get treatment faster, and to test how well this tool works and whether patients would enjoy using it.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT06096623.
PRIMARY OBJECTIVE:
I. To assess the feasibility of the Care Tracker electronic patient-reported outcomes (ePRO) treatment tracking tool in 240 newly diagnosed breast and colorectal cancer patients, defined as the proportion of consented patients who respond to at least half of weekly ePRO surveys until 8 weeks days post-enrollment or until treatment initiation is confirmed.
OUTLINE: This is an observational study.
Patients complete surveys and may complete a semi-structured interview on study. Patients' medical records are also reviewed on study.
After completion of study intervention, patients are followed up for 6 months.
Trial PhaseNo phase specified
Trial Typehealth services research
Lead OrganizationUNC Lineberger Comprehensive Cancer Center
Principal InvestigatorKatherine E. Reeder-Hayes
